Do Wall Street Analysts Like Baxter International Stock?

Baxter International Inc. (BAX), with a market cap of $17.7 billion, is a global medical technology company in the healthcare sector. The Deerfield, Illinois-based company develops and provides a range of healthcare products, including dialysis equipment, infusion systems, and surgical tools, in approximately 100 countries.

Shares of the drug and medical device maker have significantly underperformed the broader market over the past 52 weeks. BAX has declined 15.9% over this time frame, while the broader S&P 500 Index ($SPX) has soared 17%. In 2024, BAX stock is down 4.5%, compared to SPX's 9.9% gains on a YTD basis.